为评估 CRISPR-GPT 智能体的性能，该团队邀请了 8 名具有 CRISPR 和基因编辑专业知识的研究人员设计一系列任务，测试 CRISPR-GPT 协助实验设计的能力。

生命科学Life science近年来，基于CRISPR的基因编辑技术在生命科学领域掀起了一场革命，不仅极大地推动了基础研究的发展，也在临床治疗、农业育种 ...

A generative artificial-intelligence tool has designed a synthetic CRISPR system that successfully edits human DNA and sharply reduces off-target effects.

CRISPR could yet save millions of lives. Here’s how Gene-editing medicines have had a rocky start. But there is cause for optimism ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients.

The United Kingdom has become the first country to give regulatory approval to a medical treatment involving the revolutionary CRISPR gene editing tool.

The one-time gene editing fix is meant to halt debilitating pain crises for sickle cell patients, who formerly could only be cured with a risky stem cell transplant.

STAT spoke to the CEO of CRISPR Therapeutics about how the company secured a historical approval, and where the field of CRISPR-based medicine is going.